Yaobin Lin

752 total citations
50 papers, 460 citations indexed

About

Yaobin Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Yaobin Lin has authored 50 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Yaobin Lin's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Yaobin Lin is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Yaobin Lin collaborates with scholars based in China, United States and Taiwan. Yaobin Lin's co-authors include Hao Long, Yongbin Lin, Ze-Rui Zhao, Yizhi Wang, Wenyu Zhai, Long Jiang, Shanshan Jiang, Han Qi, Hui Yu and Andrew Chi-Chih Yao and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Yaobin Lin

43 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaobin Lin China 14 231 187 116 91 87 50 460
Zhaofei Pang China 14 169 0.7× 259 1.4× 152 1.3× 62 0.7× 127 1.5× 29 506
Chenglong Zhao China 13 79 0.3× 122 0.7× 162 1.4× 114 1.3× 118 1.4× 37 422
Pernelle Lavaud France 12 290 1.3× 377 2.0× 94 0.8× 46 0.5× 82 0.9× 71 551
Shuanghe Peng China 13 197 0.9× 150 0.8× 168 1.4× 65 0.7× 171 2.0× 23 379
Francesca Valcamonico Italy 10 122 0.5× 126 0.7× 88 0.8× 40 0.4× 63 0.7× 43 317
Diego Márquez-Medina Spain 10 259 1.1× 308 1.6× 102 0.9× 34 0.4× 44 0.5× 26 462
Noelia Vilariño Spain 12 323 1.4× 417 2.2× 98 0.8× 26 0.3× 48 0.6× 29 593
Yuji Hirami Japan 10 162 0.7× 222 1.2× 96 0.8× 32 0.4× 74 0.9× 21 405
Qiang Zheng China 12 353 1.5× 221 1.2× 162 1.4× 85 0.9× 81 0.9× 38 561

Countries citing papers authored by Yaobin Lin

Since Specialization
Citations

This map shows the geographic impact of Yaobin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaobin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaobin Lin more than expected).

Fields of papers citing papers by Yaobin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaobin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaobin Lin. The network helps show where Yaobin Lin may publish in the future.

Co-authorship network of co-authors of Yaobin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yaobin Lin. A scholar is included among the top collaborators of Yaobin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaobin Lin. Yaobin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yaobin, et al.. (2025). Incidence trends and prognostic factors in head and neck MALT lymphoma. Annals of Hematology. 104(1). 467–478.
2.
Ju, Gaoda, Yaobin Lin, Xiaoxue Huang, et al.. (2025). TFDP1 drives triple-negative breast Cancer development through senescence suppression and serves as a therapeutic target for topotecan. International Journal of Biological Macromolecules. 310(Pt 4). 143543–143543. 1 indexed citations
3.
Ding, Sandrine, Yue-Ming Peng, Xiaoyan Huang, et al.. (2025). Safety and Efficacy of Unresectable Malignant Cardiac Tumors Treated with Concurrent Chemoradiation Therapy Using a 1.5T MR-Linac (GASTO-1078). International Journal of Radiation Oncology*Biology*Physics. 122(4). 949–956.
4.
Liu, Shan, Yaobin Lin, & Zhihong Wang. (2025). Causal relationships between body composition and hematological malignancies: a multivariable mendelian randomization analysis. Cancer Causes & Control. 36(8). 795–802.
5.
6.
Lin, Yaobin, et al.. (2023). Comparative analysis of the mutation detection using malignant pleural effusion and blood cell-free DNA samples in lung cancer.. Journal of Clinical Oncology. 41(16_suppl). e20518–e20518.
7.
Zhai, Wenyu, Fangfang Duan, Yaobin Lin, et al.. (2023). Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy. Journal of Inflammation Research. Volume 16. 3329–3339. 13 indexed citations
8.
Lin, Yaobin, Zhichao Lin, Ming Zhou, et al.. (2023). Phase II trial of safety and efficacy of tislelizumab plus chemotherapy in stage II-IV non small cell lung cancer (LungMark).. Journal of Clinical Oncology. 41(16_suppl). 8564–8564. 1 indexed citations
9.
Liu, Shan, et al.. (2023). Metastasis pattern and prognosis in children with neuroblastoma. World Journal of Surgical Oncology. 21(1). 130–130. 27 indexed citations
10.
Lin, Zhichao, Yaobin Lin, Qingquan Luo, et al.. (2023). Invasiveness assessment by artificial intelligence against intraoperative frozen section for pulmonary nodules ≤ 3 cm. Journal of Cancer Research and Clinical Oncology. 149(10). 7759–7765. 1 indexed citations
11.
Liu, Shan, Jie Zhou, Xiangling Ye, et al.. (2023). A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development. Leukemia. 37(7). 1421–1434. 8 indexed citations
12.
Liu, Shan, et al.. (2022). Identifying the long-term survival beneficiary of chemotherapy for stage N1c sigmoid colon cancer. Scientific Reports. 12(1). 16909–16909. 2 indexed citations
13.
Lin, Yaobin, et al.. (2022). Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer. BMC Medical Genomics. 15(1). 221–221. 15 indexed citations
14.
15.
16.
Li, Jinluan, et al.. (2020). Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis. ESMO Open. 5(2). e000632–e000632. 16 indexed citations
17.
Lin, Yaobin, Jianhua Fu, Yan Huang, et al.. (2020). Fibrin sealant for esophageal anastomosis: A phase II study. World Journal of Gastrointestinal Oncology. 12(6). 651–662. 3 indexed citations
18.
Zhao, Ze-Rui, et al.. (2019). Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma. Annals of Surgical Oncology. 26(6). 1934–1941. 8 indexed citations
19.
Jiang, Long, Ze-Rui Zhao, Shanshan Jiang, et al.. (2015). Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer. Immunologic Research. 62(3). 316–324. 21 indexed citations
20.
Jiang, Long, Shanshan Jiang, Yongbin Lin, et al.. (2015). Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer. Medicine. 94(46). e2054–e2054. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaofei Pang Breakdown of academic impact, for papers by Chenglong Zhao Breakdown of academic impact, for papers by Pernelle Lavaud Breakdown of academic impact, for papers by Shuanghe Peng Breakdown of academic impact, for papers by Francesca Valcamonico Breakdown of academic impact, for papers by Diego Márquez-Medina Breakdown of academic impact, for papers by Noelia Vilariño Breakdown of academic impact, for papers by Yuji Hirami Breakdown of academic impact, for papers by Qiang Zheng
Rankless by CCL
2026